Latest AstraZeneca Stories
SOUTH SAN FRANCISCO, Calif., March 19, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody(TM) therapeutics for the treatment of cancer, today announced the appointment of
- Progress made towards 2020 targets across all six commitments BASEL, Switzerland, March 19, 2015 /PRNewswire/ -- Syngenta has published the first update on progress towards meeting the six
- Orondis offers protection against late blight, downy mildews and Phytophthora root and stem blights GREENSBORO, N.C., March 18, 2015 /PRNewswire/ -- Syngenta announced today that the trade
BEIJING, March 18, 2015 /PRNewswire/ -- Sinovac Biotech Ltd.(NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company will participate in the
BASEL, Switzerland, March 18, 2015 /PRNewswire/ -- Syngenta today announced that its 2014 Annual Report is now available at www.syngenta.com/ar2014. The
BASEL, Switzerland, March 17, 2015 /PRNewswire/ -- -- Official approval for Bt11 x GA21 stacked corn seed -- Superior control of the most damaging corn pest in ASEAN countries
- Program promotes establishment of school and community gardens that facilitate education on benefits of vegetable production and consumption GREENSBORO, N.C., March 16, 2015 /PRNewswire/
CAMBRIDGE, Mass., March 16, 2015 /PRNewswire/ -- Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA)
FREMONT, Calif., March 13, 2015 /PRNewswire/ -- Ardelyx, Inc.
DUBLIN, March 12, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has granted AstraZeneca's request for an injunction
- An armed gangster.